Interactions of the SV40 Small t Antigen and PP2A in Human Cell Transformation
Interactions of the SV40 Small t Antigen and PP2A in Human Cell Transformation
批准号:
8233031
负责人:
William C. Hahn
金额:
$32.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-01 至 2014-03-31
关键词:
AllelesAntigensBiochemicalBiochemical GeneticsBiologicalCellsComplexCritical PathwaysDNA Tumor VirusesDevelopmentEventFamilyFoundationsFundingGeneticGenetic ScreeningGoalsHumanInvestigationLeadMaintenanceMalignant NeoplasmsMammalian CellModelingMolecularMonomeric GTP-Binding ProteinsMutationOncogene ProteinsOncogenicPapovaviridaePathway interactionsPhosphorylationPhosphotransferasesPlayPrincipal InvestigatorProtein Serine/Threonine PhosphataseProtein phosphataseProteinsProto-Oncogene Proteins c-aktRegulationRodentRoleSignal PathwaySimian virus 40Specific qualifier valueTumor Suppressor ProteinsViralWorkcell transformationinsightmalignant stateprogramsresearch studytransforming virustumor growthtumor initiation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The study of DNA tumor viruses that transform rodent and human cells has led to a greater understanding of
the molecular events that program the malignant state. In particular, investigation of the viral oncoproteins
specified by the Simian Virus 40 Early Region (SV40 ER) has revealed host cell pathways, whose
perturbation play an essential role in the transformation of mammalian cells. Over the last several years, we
have focused on the role of the SV40 small t antigen (SV40ST) in human cell transformation. During the last
funding period, we have confirmed that the interaction between SV40ST and PP2A contributes directly to
human cell transformation. In addition, we have found that the perturbation of PP2A by SV40ST transforms
human cells in a manner similar to that induced by cancer-associated mutations of PP2A subunits. These
observations identify PP2A as a tumor suppressor in human cancers and suggest that a deeper
understanding of the mechanisms by which SV40ST perturbs PP2A function will provide additional insights
into tumor initiation and maintenance. In order to understand further the role(s) of PP2A in cell
transformation, we propose to combine genetic, biochemical and cell biological approaches to characterize
the PP2A complexes involved in cell transformation, to identify the role(s) of RalA in cancer development
and to elucidate the molecular pathways perturbed by SV40ST and PP2A in human cell transformation.
Investigating the regulation and function of PP2A in cancer development will not only enhance our
mechanistic understanding of this tumor suppressor family but will also provide new insights into the
pathways that help program the malignant state. In addition, these studies will provide a foundation for
strategies to target these pathways therapeutically.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of p300/CBP histone acetyltransferase inhibitors for oncogene-driven cancers
-
批准号:10627744
-
项目类别:
-
资助金额:$65.12万
-
财政年份:2022
-
负责人:William C. Hahn
-
依托单位:
Novel genetic dependencies in VRK2 methylated glioblastoma multiforme
-
批准号:10046375
-
项目类别:
-
资助金额:$17.8万
-
财政年份:2020
-
负责人:William C. Hahn
-
依托单位:
Development and implementation of multiplex methods to understand the biology and heterogeneity of patient-derived cancer models
-
批准号:10004385
-
项目类别:
-
资助金额:$100.49万
-
财政年份:2020
-
负责人:William C. Hahn
-
依托单位:
Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens
-
批准号:10250566
-
项目类别:
-
资助金额:$56.84万
-
财政年份:2017
-
负责人:William C. Hahn
-
依托单位:
PROJECT 4: Interrogating PP2A Signaling in Human Cancers
-
批准号:9981674
-
项目类别:
-
资助金额:$32.64万
-
财政年份:2017
-
负责人:William C. Hahn
-
依托单位:
Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens
-
批准号:10242454
-
项目类别:
-
资助金额:$61.16万
-
财政年份:2017
-
负责人:William C. Hahn
-
依托单位:
Systematic identification of oncogenic KRAS synthetic lethal interactions
-
批准号:9330127
-
项目类别:
-
资助金额:$80.78万
-
财政年份:2015
-
负责人:William C. Hahn
-
依托单位:
Systematic identification of oncogenic KRAS synthetic lethal interactions
-
批准号:9150537
-
项目类别:
-
资助金额:$80.78万
-
财政年份:2015
-
负责人:William C. Hahn
-
依托单位:
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center
-
批准号:9362809
-
项目类别:
-
资助金额:$102.74万
-
财政年份:2013
-
负责人:William C. Hahn
-
依托单位:
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center
-
批准号:9979771
-
项目类别:
-
资助金额:$100.76万
-
财政年份:2013
-
负责人:William C. Hahn
-
依托单位:
Discovering modulators of PAX8 for targeting ovarian cancer
-
批准号:8403869
-
项目类别:
-
资助金额:$4.38万
-
财政年份:2012
-
负责人:William C. Hahn
-
依托单位:
Identification of TBK1 inhibitors in KRAS-dependent lung cancer
-
批准号:8237125
-
项目类别:
-
资助金额:$42.96万
-
财政年份:2012
-
负责人:William C. Hahn
-
依托单位:
Discovering modulators of PAX8 for targeting ovarian cancer
-
批准号:8548405
-
项目类别:
-
资助金额:$4.24万
-
财政年份:2012
-
负责人:William C. Hahn
-
依托单位:
Project 2: Identification of combination therapy for KRAS-driven lung cancers.
-
批准号:10231099
-
项目类别:
-
资助金额:$28.86万
-
财政年份:2012
-
负责人:William C. Hahn
-
依托单位:
Gene Function Manipulation Core
-
批准号:8233036
-
项目类别:
-
资助金额:$20.59万
-
财政年份:2011
-
负责人:William C. Hahn
-
依托单位:
Druggable Genetic Lesions in Pediatric Astrocytoma
-
批准号:8044508
-
项目类别:
-
资助金额:$38.15万
-
财政年份:2011
-
负责人:William C. Hahn
-
依托单位:
Investigations on the role of the CDK8 oncogene in colon cancer
-
批准号:8204832
-
项目类别:
-
资助金额:$39.12万
-
财政年份:2010
-
负责人:William C. Hahn
-
依托单位:
Investigations on the role of the CDK8 oncogene in colon cancer
-
批准号:8408803
-
项目类别:
-
资助金额:$36.76万
-
财政年份:2010
-
负责人:William C. Hahn
-
依托单位:
Investigations on the role of the CDK8 oncogene in colon cancer
-
批准号:8102937
-
项目类别:
-
资助金额:$39.14万
-
财政年份:2010
-
负责人:William C. Hahn
-
依托单位:
Investigations on the role of the CDK8 oncogene in colon cancer
-
批准号:8594230
-
项目类别:
-
资助金额:$37.92万
-
财政年份:2010
-
负责人:William C. Hahn
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: